FTC sues significant pharmacy advantage professionals more than insulin prices The company brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of everyday living-conserving insulin drugs. The offer have to be completed by Sept. thirty or potential buyers https://kethek.com/